90-122
FINALPhiladelphia
76ers
27-55|L10: 2-8
Chicago
Bulls
42-44|L10: 5-5
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Chicago Bulls
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 61-21 | 0.744 | — | |
| 2 |
| Opponent | Date | Result |
|---|---|---|
| 2/19 | W 106-94 | |
| 2/16 |
| 58-23 |
| 0.716 |
| 2.5 |
| 3 | 53-28 | 0.654 | 7.5 |
| 4 | 49-32 | 0.605 | 11.5 |
| 5 | 46-35 | 0.568 | 14.5 |
| 6 | 46-36 | 0.561 | 15.0 |
| 7 | 41-40 | 0.506 | 19.5 |
| 8 | 40-41 | 0.494 | 20.5 |
| 9 | 32-50 | 0.390 | 29.0 |
| 10 | 89-148 | 0.376 | 49.5 |
| 11 | 29-53 | 0.354 | 32.0 |
| 12 | 27-55 | 0.329 | 34.0 |
| 13 | 27-55 | 0.329 | 34.0 |
| 14 | 26-56 | 0.317 | 35.0 |
| 15 | 0-0 | 0.000 | 20.0 |
| 2/10 | L 93-104 |
| 2/9 | W 119-97 |
| 2/6 | W 102-95 |
| Opponent | Date | Result |
|---|---|---|
| 2/19 | W 100-94 | |
| 2/17 | W 115-109 | |
| 2/16 | W 118-85 | |
| 2/10 | L 87-107 | |
| 2/9 | W 109-101 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 17.1 | 44.4% | 31.5% | 67.0% | |
| 14.0 | 46.2% | 31.3% | 75.0% | |
| 13.9 | 39.9% | 20.0% | 73.4% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 21.5 |
| 48.4% |
| 11.2% |
| 71.6% |
| 17.5 | 46.1% | 24.5% | 67.4% |
| 12.6 | 41.3% | 37.2% | 61.8% |
| Category | CHI Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #2482.0 ORtg | #23109.4 DRtg | Even |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #1111.3% | #1214.6% | Even |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #2732.5% | #2839.5% | Even |
| Category | CHI Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #11104.1 DRtg | #1983.7 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #2213.3% | #2111.9% | Even |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1235.1% | #2333.9% | PHI |
